Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Sjörgren's syndrome treated with bromhexine: a randomised clinical study.

Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Abstract Text:

    Existing treatment for Sjögren's syndrome is unsatisfactory, and uncontrolled observations have suggested that bromhexine may be effective. Twenty-nine patients with Sjögren's syndrome were therefore assigned to two randomised double-blind crossover trials with bromhexine and placebo, each comprising two two-week periods. In the first trial bromhexine 24 mg/day was given by mouth; in the second the dose was increased to 48 mg/day. After each treatment period the Schirmer test response, break-up time, Bijsterveld score, and the time taken for the patient to eat a dry biscuit were recorded, as well as the patient's estimate of moistness in the eyes and mouth. In the second (higher-dose) trial values on the Schirmer test were significantly higher after bromhexine than after placebo and the break-up time was also increased after bromhexine, which suggested that the drug has a dose-dependent effect on lacrimal gland secretion in Sjögren's syndrome. It had no effect on salivary gland function. Bromhexine is therefore valuable in the treatment of Sjögren's syndrome.

    Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Journal Published:

    PUBLICATION TYPE: Randomized Controlled Trial

    Journal: British medical journal

    VOLUME: 1

    Page Numbers: 1579-81

    Journal Abbreviation: Br Med J

    ISSN: 0007-1447

    DAY: 17

    MONTH: Jun

    YEAR: 1978

    Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372673

    Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Keywords Mesh Terms:

    KEYWORDS: Sjogren's Syndrome

    MESH TERMS: drug therapy

    Chemical & Substance for Abstract: Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Information

    Substance Name: Bromhexine

    Registry Number: 3572-43-8

    Grant and Affiliation Information for Sjörgren's syndrome treated with bromhexine: a randomised clinical study.

    AFFILIATION:

    Country: ENGLAND

    ENGLAND Research PublicationENGLAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Br Med J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Sjörgren's syndrome treated with bromhexine: a randomised clinical study Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News